Viney Joanne L.

See RemarksPandion Therapeutics, Inc. (PAND) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2021Tender(U)503K$60.00$30.2M0
Apr 1, 2021Tender(U)1K$60.00$72K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2021Disposed to issuer(D)74K0
Apr 1, 2021Disposed to issuer(D)115K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-014467) within minutes of acceptance. Every field above traces to the original document. Verify it directly: